HNGE· Health Care› Health Information Services

Hinge Health, Inc. Class A

Stage 2 · Advancing · week 20

As of Oct 22, 2026, Hinge Health is in Stage 2, the uptrend phase, now in week 20 (since Jun 4, 2026). It closed at $109.93, 1.1% below its 52-week high and above its 200-day average, which is rising.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. More about the company

$109.93

-1.05% today

$8.9B · Mid cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 16 in Health Information Services · #1 of 272 in Health Care

Is HNGE early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2025-05-22 → 2026-10-22

S? 42w

S4 6w

S1 6w

S2 20w

2025-05-222026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S? 42w → S4 6w → S1 6w → S2 20w current

Total tracked: 74 weeks across 4 stage runs.

HNGE among Health Information Services2nd of 41 by relative strength

All 41 →

Stocks in Health Information Services ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	AMWLAmerican Well Corporation Class A	Stage 2 · wk 25	97	+7.4%
2	HNGEHinge Health, Inc. Class A	Stage 2 · wk 20	96	+19.1%
3	BTSGBrightSpring Health Services, Inc.	Stage 3 · wk 8	94	+9.1%
4	NRCNRC Health	Stage 3 · wk 4	93	−0.1%
5	SOPHSOPHiA GENETICS SA	Stage 2 · wk 24	91	−12.7%
6	HTFLHeartflow, Inc.	Stage 2 · wk 10	87	+17.0%
7	HSTMHealthStream, Inc.	Stage 2 · wk 17	77	+20.3%
8	OMCLOmnicell, Inc.	Stage 4 · wk 10	70	+12.5%

vs 52W High

-1.1%

$31.17 lo$111.10 hi

Near 52W high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 20

1w13w26w

Week 20, proven structure

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

69.0%

200 DMA: $65.06 · rising

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

1.25x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↑

Short-term trend rising strongly

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+19.1%

+47.9%

+154.2%

YTD

+141.3%

+121.0%

Scan Membership

Not in any current scan.

Recent Stage Timeline

2026-10-22S2

Wk 20 · Vol 1.25x

2026-10-21S2

Wk 20 · Vol 0.95x

2026-10-20S2

Wk 20 · Vol 2.29x

2026-10-19S2

Wk 19 · Vol 0.68x

2026-10-16S2

Wk 19 · Vol 0.97x

2026-10-15S2

Wk 19 · Vol 0.90x

2026-10-14S2

Wk 19 · Vol 0.86x

2026-10-13S2

Wk 19 · Vol 0.46x

2026-10-12S2

Wk 18 · Vol 0.71x

2026-10-09S2

Wk 18 · Vol 0.90x

2026-10-08S2

Wk 18 · Vol 0.48x

2026-10-07S2

Wk 18 · Vol 1.42x

Moving averages & range

50 DMA

$95.00

200 DMA

$65.06

52W High

$111.10

52W Low

$31.17

5D Low

$99.16

Resistance levels (recent highs)

20d High

$111.10

60d High

$111.10

120d High

$111.10

250d High

$111.10

Next resistance

+1.1%

to 20d High

P/E (TTM)

36.3

Forward 36.0

ROE

+30.4%

Profit margin +15.1%

Dividend Yield

0.00%

P/B 25.6

Hinge Health: quick answers

What stage is Hinge Health in?

As of Oct 22, 2026, Hinge Health (HNGE) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 4, 2026 and is in week 20. What the four stages mean

Is Hinge Health in an uptrend?

Yes. Hinge Health is in a Stage 2 uptrend. It trades 69.0% above its 200-day average, which is rising.

How far is Hinge Health from its 52-week high?

Hinge Health closed at $109.93 on Oct 22, 2026, 1.1% below its 52-week high of $111.10. Its 52-week low is $31.17.

How has Hinge Health performed over the past year?

As of Oct 22, 2026, Hinge Health is up 121.0% over the past year and up 141.3% so far in 2026.

Which sector and industry is Hinge Health in?

Hinge Health is in the Health Information Services industry, part of the Health Care sector.

About this companyHealth Care· Health Information Services

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.